China Oral Industry Group Holdings Limited (8406) AI Stock Analysis

• Market Cap: HK$135.43M
• Dividend Yield: N/A
• Average Volume (3M): 7.17M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.28
• Revenue Growth: 35.26%
• EPS Growth: 26.07%
• Country: HK
• Employees: 608
• Sector: Consumer Cyclical
• Sector Strength: 57
• Industry: Leisure
• EPS (TTM): N/A
• Shares Outstanding: 1,368,000,000
• 10 Day Avg. Volume: 8,799,000
• 30 Day Avg. Volume: 7,174,666
• PEG Ratio: >-0.01
• Price to Book (P/B): 1.71
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 14.16
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 46 Neutral
• Price Target: ―

China Oral Industry Group Holdings Limited is facing significant financial and operational challenges. The decline in revenue and profitability, combined with weak technical indicators and unattractive valuation metrics, results in a low overall stock score. Without positive earnings call insights or corporate events to offset these issues, the stock remains a high-risk investment.

China Oral Industry Group Holdings Limited Business Overview & Revenue Model

Company Description

China Oral Industry Group Holdings Limited (8406) is a company involved in the development, manufacturing, and sale of oral care products. It operates in the healthcare sector, focusing on providing a range of dental and oral hygiene products that cater to various consumer needs. The company aims to enhance oral health through innovation and high-quality products.

How the Company Makes Money

China Oral Industry Group Holdings Limited generates revenue primarily through the sale of its oral care products. This includes items such as toothpaste, toothbrushes, mouthwash, and other dental hygiene products. The company may also engage in partnerships with dental professionals and retailers to distribute its products more effectively. Additionally, the company may invest in marketing and brand development to increase its market share and consumer base, contributing to its earnings. Significant factors contributing to its revenue include product innovation, market expansion efforts, and maintaining competitive pricing strategies.

China Oral Industry Group Holdings Limited Financial Statement Overview

Summary

China Oral Industry Group Holdings Limited is experiencing financial difficulties, with declining revenue and profitability, as well as operational inefficiencies. Despite low leverage, ongoing net losses and cash flow volatility pose risks to financial stability, necessitating strategic interventions.

Income Statement

The company has shown a decline in revenue over recent years. The gross profit margin has decreased from 28.7% in 2020 to 16.1% in 2024, indicating rising costs or pricing pressures. The net profit margin has turned negative, with a net loss in recent periods. EBIT and EBITDA margins are also negative, reflecting operational challenges.

Balance Sheet

The company's debt-to-equity ratio is low at 0.04, indicating conservative leverage. However, the equity ratio has decreased slightly over time, suggesting a decline in asset efficiency. ROE has been negative due to consecutive net losses, pointing to inefficiencies in generating returns on equity.

Cash Flow

The firm experienced volatility in operating cash flow, with periods of negative cash flow, impacting liquidity. Free cash flow has fluctuated significantly, with recent years showing declines. The free cash flow to net income ratio is not meaningful due to negative net income.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
230.96M	166.92M	212.52M	294.92M	260.74M
	Gross Profit
37.25M	27.04M	17.57M	59.86M	74.91M
	EBIT
-9.44M	-12.55M	-21.54M	8.45M	30.58M
	EBITDA
-7.77M	-12.55M	-27.38M	15.22M	36.14M
	Net Income Common Stockholders
-16.44M	-18.63M	-34.85M	-2.13M	23.56M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
67.05M	76.32M	60.28M	25.59M	52.11M
	Total Assets
202.46M	183.78M	190.85M	202.91M	180.80M
	Total Debt
4.68M	14.57M	15.79M	19.99M	22.09M
	Net Debt
-52.37M	-41.75M	-13.59M	-5.60M	-30.02M
	Total Liabilities
95.32M	79.11M	67.70M	84.20M	58.89M
	Stockholders Equity
107.14M	104.67M	123.15M	118.71M	121.91M
Cash Flow		Free Cash Flow
0.00	29.35M	14.90M	-21.03M	19.31M
	Operating Cash Flow
0.00	31.32M	28.15M	-19.15M	34.63M
	Investing Cash Flow
0.00	1.08M	-56.86M	-842.00K	-15.23M
	Financing Cash Flow
0.00	-6.00M	31.63M	-5.45M	-10.62M

China Oral Industry Group Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.10
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8406, the sentiment is Positive. The current price of 0.1 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.09, and above the 200-day MA of 0.09, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 56.06 is Neutral, neither overbought nor oversold. The STOCH value of 31.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8406.

China Oral Industry Group Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1093	76 Outperform	$87.51B	19.03	13.20%	2.63%	-9.60%	-27.18%
3600	74 Outperform	€3.77B	9.31	15.04%	35.93%	6.05%	1.32%
6869	70 Outperform	$23.37B	16.29	6.68%	3.16%	0.24%	-31.74%
Sector *	62 Neutral	$6.76B	11.06	2.80%	6.66%	2.68%	-24.89%
3320	62 Neutral	€31.98B	8.80		7.13%	―	―
1518	59 Neutral	HK$444.17M	8.56	8.82%	2.43%	-10.82%	-43.85%
8406	46 Neutral	HK$135.43M	―	-15.56%	―	35.26%	26.07%